Preview this article 1 min Biogen is buying a Boston-area biotech that already has two approved drugs to drive short-term and ...
Where Buc-ee's could land next in North Carolina $50M project could boost Eastern NC city's prospects $50M project could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results